E.A. Helmbold
- Genetics top 1%
- Vascular Anomalies and Treatments 5
- BRCA gene mutations in cancer 2
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
-
- Tracheal and airway disorders 2
- Marketing top 5%
- Sharing Economy and Platforms 1
- Neurology top 5%
- Surgery top 10%
-
- Vascular Tumors and Angiosarcomas 1
- Peptidase Inhibition and Analysis 1
-
- Cancer Genomics and Diagnostics 1
- Co-authors
- Dorene S. MarkelCharles E. JacksonDouglas A. MarchukDavid W. JohnsonCarol J. GallioneKimberly A. McAllisterMary PorteousAlan E. Guttmacher
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
E.A. Helmbold
8 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Genetics 911
- Pulmonary and Respiratory Medicine 769
- Marketing 191
- Neurology 257
- Surgery 431
Countries citing papers authored by E.A. Helmbold
This map shows the geographic impact of E.A. Helmbold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.A. Helmbold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.A. Helmbold more than expected).
Fields of papers citing papers by E.A. Helmbold
This network shows the impact of papers produced by E.A. Helmbold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.A. Helmbold. The network helps show where E.A. Helmbold may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E.A. Helmbold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 3 | |
| 2 | 1995 | 124 | |
| 3 | 1995 | 105 | |
| 4 | 1994 | 79 | |
| 5 | Genetic heterogeneity in hereditary hemorrhagic telangiectasia: Possible correlation with clinical phenotype | 1994 | 9 |
| 6 | Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1breakdown → | 1994 | 1137 |
| 7 | 1994 | 120 | |
| 8 | BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis. | 1993 | 39 |
About E.A. Helmbold
E.A. Helmbold is a scholar working on Genetics, Marketing and Oncology, having authored 8 papers that have together received 1.6k indexed citations. Recurring topics across this work include Vascular Anomalies and Treatments (5 papers), BRCA gene mutations in cancer (2 papers), Tracheal and airway disorders (2 papers), Vascular Tumors and Angiosarcomas (1 paper), Sharing Economy and Platforms (1 paper), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Cancer Genomics and Diagnostics (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Genetics (911 citations), Pulmonary and Respiratory Medicine (769 citations) and Marketing (191 citations). E.A. Helmbold has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Dorene S. Markel, Charles E. Jackson, Douglas A. Marchuk, David W. Johnson, Carol J. Gallione, Kimberly A. McAllister, Mary Porteous, Alan E. Guttmacher, Wendy McKinnon and M. A. Pericak‐Vance. Their work appears in journals such as Journal of Medical Genetics, Nature Genetics, Genome Research, The American Journal of Human Genetics and Cancer Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.